Corporate spy, Ray Zy-Dyent, interviews at a major pharmaceutical competitor to access incriminating evidence for the government.
The government recruits a scientist to go undercover as a spy to gather information about a serum to cure the rampant disease.
The largest pharma-tech company weighs the advantages of a consortium to battle a global health crisis.
A major entity within the pharmaceutical consortium discusses the ramifications of the President’s international speech.
Premiere: As the year 2100 approaches, this world teeters on the edge of a new era—or human extinction in this novella miniseries.
The detective gathers many clues pointing to a man who has been missing for 20 years until new evidence comes to light in the ending of this mystery story.
After watching the home of the crime scene for two days, someone shows up with possibly incriminating evidence.
Premiere: In this case, a detective is called to a crime scene with no victim, no motive, and plenty of clues.
Anecdotal studies from the youthful cures provide a compelling addendum to prior research for holistic approaches to traditional illnesses.
Miss Chambers finds herself answering for the activities of her students even when she is not instructing them.
As children grow older, they discover creative uses for their medical talents, even if they do not always fall within the boundaries of the law.
Miss Chambers navigates the challenge of having a child fall ill on an unsanctioned field trip.
Featured authors and reviewers
This information does not constitute professional medical care or legal advice. Discuss personal concerns with your doctor or legal advisor.